Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

We compared the effects of GK-2 (dimeric dipeptide mimetic of nerve growth factor) and Mexidol (standard preparation for the therapy of stroke) on rat model of transient occlusion of the middle cerebral artery. GK-2 and Mexidol were administered intraperitoneally in the most active doses (1 and 100 mg/kg, respectively) 6 h after surgery and then once a day for 6 days. The preparations reduced the volume of cerebral infarction (by 60 and 30%, respectively). At the same time, GK-2 had a pronounced and statistically more reliable effect in a dose that is lower by two orders of magnitude. In addition, GK-2 significantly reduced the neurological deficit in the limb placement test, while Mexidol was ineffective in this test.

Авторлар туралы

P. Povarnina

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Хат алмасуға жауапты Автор.
Email: povarnina@gmail.com
Ресей, Moscow

A. Volkova

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Ресей, Moscow

T. Gudasheva

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Ресей, Moscow

S. Seredenin

Department of Pharmacogenetics, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Ресей, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>